Association Between Obesity and Cervical Cancer Severity: A Retrospective Cross-Sectional Study in Surabaya, Indonesia
Abstract
Cervical cancer remains a major global cause of morbidity and mortality, with obesity increasingly identified as a risk-modifying factor that accelerates disease progression through chronic inflammation, insulin resistance, and elevated endogenous estrogen levels. This study aimed to evaluate the association between obesity and cervical cancer severity among patients treated at Dr. Mohamad Soewandhie General Hospital in Surabaya from January 2023 to December 2024. A retrospective cross-sectional design was employed, with data extracted from the medical records of 46 patients recruited via purposive sampling using Slovin's formula. Variables included Body Mass Index (BMI), classified according to WHO Asian-specific cut-off points, and cervical cancer stage, based on the International Federation of Gynecology and Obstetrics (FIGO) classification. The findings indicate that Obesity I and Obesity II collectively accounted for 52.2% of the cohort. Furthermore, the majority of patients presented at advanced stages, predominantly Stage IIIB (43%) and Stage IVB (20%). Spearman's rank correlation revealed a significantly strong positive association between obesity and cervical cancer severity (rₛ = 0.632, p < 0.01). It is concluded that higher BMI categories are consistently associated with more advanced disease staging at diagnosis.